These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36732902)

  • 1. Speech biomarkers in Huntington's disease: A cross-sectional study in pre-symptomatic, prodromal and early manifest stages.
    Kouba T; Frank W; Tykalova T; Mühlbäck A; Klempíř J; Lindenberg KS; Landwehrmeyer GB; Rusz J
    Eur J Neurol; 2023 May; 30(5):1262-1271. PubMed ID: 36732902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Language disintegration in spontaneous speech in Huntington's disease: a more fine-grained analysis.
    Tovar A; Garí Soler A; Ruiz-Idiago J; Mareca Viladrich C; Pomarol-Clotet E; Rosselló J; Hinzen W
    J Commun Disord; 2020; 83():105970. PubMed ID: 32062158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
    Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
    J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech acoustic markers of early stage and prodromal Huntington's disease: a marker of disease onset?
    Vogel AP; Shirbin C; Churchyard AJ; Stout JC
    Neuropsychologia; 2012 Dec; 50(14):3273-8. PubMed ID: 22982606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual Object Perception in Premanifest and Early Manifest Huntington's Disease.
    Coppen EM; Jacobs M; van der Zwaan KF; Middelkoop HAM; Roos RAC
    Arch Clin Neuropsychol; 2019 Nov; 34(8):1320-1328. PubMed ID: 30796801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speech in prodromal and symptomatic Huntington's disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases.
    Chan JCS; Stout JC; Vogel AP
    Neurosci Biobehav Rev; 2019 Dec; 107():450-460. PubMed ID: 31419452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic linguistic profile of spontaneous narrative speech in pre-symptomatic and early stage Huntington's disease.
    Hinzen W; Rosselló J; Morey C; Camara E; Garcia-Gorro C; Salvador R; de Diego-Balaguer R
    Cortex; 2018 Mar; 100():71-83. PubMed ID: 28859906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.
    Unmack Larsen I; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2015 Mar; 21(3):193-202. PubMed ID: 25850430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
    Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
    Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listener Detection of Objectively Validated Acoustic Features of Speech in Huntington's Disease.
    Chan JCS; Stout JC; Shirbin CA; Vogel AP
    J Huntingtons Dis; 2022; 11(1):71-79. PubMed ID: 34974436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phonatory dysfunction as a preclinical symptom of Huntington disease.
    Rusz J; Saft C; Schlegel U; Hoffman R; Skodda S
    PLoS One; 2014; 9(11):e113412. PubMed ID: 25409322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered driving performance of symptomatic Huntington's disease gene carriers in simulated road conditions.
    Jacobs M; Hart EP; Miranda YM; Groeneveld GJ; van Gerven JMA; Roos RAC
    Traffic Inj Prev; 2018; 19(7):708-714. PubMed ID: 30273496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontostriatal Circuits Alterations Associated with Cognitive Flexibility Deterioration in Huntington's Disease.
    Padron-Rivera G; Romero-Molina AO; Diaz R; Vaca-Palomares I; Ochoa-Morales A; Romero-Rebollar C; Chirino-Pérez A; Fernandez-Ruiz J
    Neurodegener Dis; 2022; 22(1):24-28. PubMed ID: 36067733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington's disease.
    Murueta-Goyena A; Del Pino R; Acera M; Teijeira-Portas S; Romero D; Ayala U; Fernández-Valle T; Tijero B; Gabilondo I; Gómez Esteban JC
    J Neurol; 2023 Aug; 270(8):3821-3829. PubMed ID: 37079031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic criteria for Huntington's disease based on natural history.
    Reilmann R; Leavitt BR; Ross CA
    Mov Disord; 2014 Sep; 29(11):1335-41. PubMed ID: 25164527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objective assessment of gait and posture in premanifest and manifest Huntington disease - A multi-center study.
    Beckmann H; Bohlen S; Saft C; Hoffmann R; Gerss J; Muratori L; Ringelstein EB; Landwehrmeyer GB; Reilmann R
    Gait Posture; 2018 May; 62():451-457. PubMed ID: 29660633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation between decision-making under risk and decision-making under ambiguity in premanifest and manifest Huntington's disease.
    Adjeroud N; Besnard J; Verny C; Prundean A; Scherer C; Gohier B; Bonneau D; Massioui NE; Allain P
    Neuropsychologia; 2017 Aug; 103():87-95. PubMed ID: 28712946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
    Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
    Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.